6397 RESULTS
Sort By:
Sixth Int. Conference on AD: Mechanisms of Neurodegenerative Conditions I Sixth Int. Conference on AD: Genetics I Sixth Int. Conference on AD: Monkey Brain Injections Sixth Int. Conference on AD: Cellular/Animal Models I Sixth Int. Conference on AD: Mecha
Synapses Sizzle in Limelight of Symposium Preceding Neuroscience Conference, Orlando: Day I Synapses Sizzle in Limelight of Symposium Preceding Neuroscience Conference, Orlando: Day 2 Orlando Conference: Hyperphosphorylation—It's Not Just Tau's
In today's SciencExpress, researchers from Italy, France, and The Netherlands report that mutations in DJ-1, a protein of unknown function, can lead to Parkinson's disease...
Researchers led by Don Lo of Duke University Medical Center and Cogent Neuroscience, Inc., in Durham, North Carolina, have developed a novel brain-slice platform for identifying therapeutic targets for neurodegenerative diseases...
People diagnosed with Alzheimer's disease at age 65 will likely live more than twice as long as those diagnosed at age 90, according to a study in the current issue of the Archives of Neurology...
Embryonic stem (ES) cells have the inherent potential to replace or repair almost every tissue in the body. One key to this prowess is the ability to migrate...
Insulin resistance is emerging as a possible risk factor for Alzheimer’s, and data from a pilot trial presented at the 2002 Neuroscience meeting indicate that an insulin-sensitizing drug may represent a novel treatment approach...
Assays of Aβ or tau protein in cerebrospinal fluid can identify Alzheimer's disease in patients with mild cognitive impairment, say the authors of a study in today’s Archives of Neurology...
Two studies indicate that the amyloid deposits found in the hippocampus may come not so much from local cells but arrive via the axons of distant neurons projecting there...
The replacement of dying neurons in Alzheimer’s disease with neural stem cells remains a pie in the sky, but at least researchers now appear to have gotten their hands on the filling...
Aβ immunotherapists are back at the drawing board after inflammatory complications scuttled the first clinical trial...
Preliminary results of the NGF gene therapy clinical trial in early-stage AD illustrate the potential promise—and pitfalls—of gene therapy for neurodegenerative diseases...
Use of hormone replacement therapy (HRT) appears to protect some women from Alzheimer's disease, according to a prospective observational study of AD risk factors published in this week's JAMA...
It may not be the Oscars or Nobel prize, but recipients of the second annual Alzheimer Research Forum Awards were warmly applauded at the Society for Neuroscience meeting....
In three posters on Wednesday here at the annual Neuroscience meeting, <strong>William Klein's</strong> laboratory extended their earlier presentation to add new pieces to the puzzle of the amyloid cascade hypothesis...
